Prevention of cerebrovascular and cardiovascular Events of ischaemic origin with teRutroban in patients with a history oF ischaemic stroke or tRansient ischaeMic attack - PERFORM


The goal of the trial was to evaluate treatment with the selective thromboxane-prostaglandin antagonist terutroban compared with aspirin among patients with recent ischemic stroke or transient ischemic attack (TIA).